Doximity Inc (DOCS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Doximity Inc (DOCS) has a cash flow conversion efficiency ratio of 0.115x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($109.52 Million) by net assets ($950.84 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Doximity Inc balance sheet quality to measure how much of total assets are equity-financed.
Doximity Inc - Cash Flow Conversion Efficiency Trend (2019–2026)
This chart illustrates how Doximity Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check DOCS cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Doximity Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Doximity Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Xometry Inc
NASDAQ:XMTR
|
0.021x |
|
Bravida Holding AB
ST:BRAV
|
0.037x |
|
Ardagh Metal Packaging SA
NYSE:AMBP
|
-0.542x |
|
Koza Altin Isletmeleri AS
IS:KOZAL
|
0.128x |
|
Union Bank of Taiwan
TW:2838
|
-0.031x |
|
Shenzhen Intellifusion Technologies Co. Ltd. A
SHG:688343
|
N/A |
|
Autobio Diagnostics Co Ltd
SHG:603658
|
0.049x |
|
Piramal Pharma Limited
NSE:PPLPHARMA
|
0.109x |
Annual Cash Flow Conversion Efficiency for Doximity Inc (2019–2026)
The table below shows the annual cash flow conversion efficiency of Doximity Inc from 2019 to 2026. For the full company profile with market capitalisation and key ratios, see Doximity Inc market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | $950.84 Million | $326.46 Million | 0.343x | +36.02% |
| 2025-03-31 | $1.08 Billion | $273.26 Million | 0.252x | +23.59% |
| 2024-03-31 | $901.40 Million | $184.10 Million | 0.204x | +9.86% |
| 2023-03-31 | $966.12 Million | $179.60 Million | 0.186x | +29.04% |
| 2022-03-31 | $878.59 Million | $126.58 Million | 0.144x | -88.41% |
| 2021-03-31 | $66.74 Million | $82.97 Million | 1.243x | -94.61% |
| 2020-03-31 | $1.14 Million | $26.20 Million | 23.063x | +7246.07% |
| 2019-03-31 | $48.75 Million | $15.31 Million | 0.314x | -- |
About Doximity Inc
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussio… Read more